🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Temozolomide - Medicines in Ireland

31 authorised products containing Temozolomide, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 31 authorised medicines
MedicineActive substanceLicence holderStatus
Temodal 2.5 mg/ml powder for solution for infusion
EU/1/98/096/023
 Temozolomide Merck Sharp & Dohme BV —
Temomedac 100 mg hard capsules
EU/1/09/605/5-6
 Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH —
Temomedac 140 mg hard capsules
EU/1/09/605/7-8
 Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH —
Temomedac 180 mg hard capsules
EU/1/09/605/9-10
 Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH —
Temomedac 20 mg hard capsules
EU/1/09/605/3-4
 Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH —
Temomedac 250 mg hard capsules
EU/1/09/605/11-12
 Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH —
Temomedac 5 mg hard capsules
EU/1/09/605/1-2
 Temozolomide medac Gesellschaft für klinische Spezialpräparate mbH —
Temozolomide Accord 100 mg hard capsules
EU/1/10/615/009-010
 Temozolomide Accord Healthcare S.L.U. —
Temozolomide Accord 140 mg hard capsules
EU/1/10/615/013-014
 Temozolomide Accord Healthcare S.L.U. —
Temozolomide Accord 180 mg hard capsules
EU/1/10/615/017-018
 Temozolomide Accord Healthcare S.L.U. —
Temozolomide Accord 20 mg hard capsules
EU/1/10/615/005-006
 Temozolomide Accord Healthcare S.L.U. —
Temozolomide Accord 250 mg hard capsules
EU/1/10/615/021-022
 Temozolomide Accord Healthcare S.L.U. —
Temozolomide Accord 5 mg hard capsules
EU/1/10/615/001-002
 Temozolomide Accord Healthcare S.L.U. —
Temozolomide Clonmel 100mg hard capsules
PA0126/188/003
 Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 140mg hard capsules
PA0126/188/004
 Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 180 mg hard capsules
PA0126/188/005
 Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 20 mg hard capsules
PA0126/188/002
 Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 250 mg hard capsules
PA0126/188/006
 Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide Clonmel 5mg hard capsules
PA0126/188/001
 Temozolomide Clonmel Healthcare Ltd Marketed
Temozolomide FAIR-MED 100 mg hard capsules
PA23270/002/003
 Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 140 mg hard capsules
PA23270/002/004
 Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 180 mg hard capsules
PA23270/002/005
 Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 20 mg hard capsules
PA23270/002/002
 Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 250 mg hard capsules
PA23270/002/006
 Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide FAIR-MED 5 mg hard capsules
PA23270/002/001
 Temozolomide Thrive Pharma Ltd. Not marketed
Temozolomide Teva 100 mg hard capsules
EU/1/09/606/005-006
 Temozolomide Teva B.V. —
Temozolomide Teva 140 mg hard capsules
EU/1/09/606/007-008
 Temozolomide Teva B.V. —
Temozolomide Teva 180 mg hard capsules
EU/1/09/606/009-010
 Temozolomide Teva B.V. —
Temozolomide Teva 20 mg hard capsules
EU/1/09/606/003-004
 Temozolomide Teva B.V. —
Temozolomide Teva 250 mg hard capsules
EU/1/09/606/011-012
 Temozolomide Teva B.V. —
Temozolomide Teva 5 mg hard capsules
EU/1/09/606/001-002
 Temozolomide Teva B.V. —
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.